http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2423125-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54b9f7b1f158b8ce996be7803b63c710 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a6907c0df7c11e72803b375909e45fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate | 2010-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24e34061e2a1cd64e44610a83a872621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c28a0195c0d3c7582f2138f0363c1147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf9ff521b5ce4ae9f3c86d9102c5d0b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef735f16b01f47a3fe51c1f2187fd3a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7129a8989a04e2633ccb9fa639e8ea15 |
| publicationDate | 2011-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2423125-C1 |
| titleOfInvention | Method of evening-out dysfunctions of vascular wall in patients with arterial hypertension of iii degree with metabolic syndrome, after thrombosis of eye vessels |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to cardiology and angiology, and deals with correction of functions of vascular walls in patients with arterial hypertension of III degree with metabolic syndrome, after thrombosis of eye vessels. For this purpose indices of anti-aggregate, anti-coagulant and fibrinolytic activity of vascular wall are determined. On the basis of said indices calculated is total anti-thrombotic potential of vessels and if its value is 0.069 and lower, complex treatment, including application of individually selected hypocaloric diet, dosed physical load, pioglitazone 30 mg 1 time per day and valsartan 80 mg 1 time per day in the morning and amlodipine 10 mg 1 time per day during 4 months, is administered. n EFFECT: complex of drug and non-drug therapy in combination with empirically selected duration of treatment ensures correction of functions of vascular wall and, thus, reduction, of risk of thrombotic complications in said group of patients due to potentiation of therapeutic effect of separate components of therapeutic complex. n 1 ex, 1 dwg |
| priorityDate | 2010-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.